Microvascular decompression for trigeminal neuralgia: A retrospective analysis of long-term outcomes and prognostic factors
Cirugía de neuralgia del trigémino
Pain
Neuralgia del trigémino refractaria
Middle Aged
Trigeminal Neuralgia
Compresión neurovascular
Prognosis
3. Good health
Microvascular Decompression Surgery
03 medical and health sciences
Treatment Outcome
0302 clinical medicine
Humans
Neurology. Diseases of the nervous system
RC346-429
Aged
Retrospective Studies
DOI:
10.1016/j.nrleng.2021.03.010
Publication Date:
2023-11-22T01:59:13Z
AUTHORS (6)
ABSTRACT
Microvascular decompression is considered to be the most effective and only etiological surgical treatment for classical trigeminal neuralgia, relieving the neurovascular compression found in up to 95% of cases. This study aims to report the long-term outcomes and to identify prognostic factors in a series of patients with trigeminal neuralgia treated by microvascular decompression.A retrospective observational study of 152 consecutive patients operated by microvascular decompression with at least six months of follow-up. The surgical results, including pain relief according to the Barrow Neurological Institute pain scale, complications and the medical treatment during the follow-up period were reviewed. Binary regression analysis was performed to identify factors associated with a good long-term outcome.A total of 152 patients with a mean age of 60 years and a mean follow-up of 43 months were included. At the final follow-up visit, 83% of the patients had achieved significant relief of the pain and 63% could reduce the absolute drug doses by 50% or more. The most frequent complications were wound infection (4.5%) and CSF fistula (7%). Being over 70 years of age and having paroxysmal pain were associated with a long-term pain relief.Our results support the notion that microvascular decompression is an effective and safe therapy in patients with trigeminal neuralgia. A multidisciplinary approach with an early referral to a neurosurgical unit many be beneficial in patients who are refractory to pharmacological treatment.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (52)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....